Cargando…

1210. Staphylococcal Acute Post-Operative Prosthetic Joint Infection (PJI) Treated With “DAIR” (Debridement and Implant Retention) and Impact of Rifampin: A Retrospective Cohort Study in France

BACKGROUND: Staphylococci are the most frequent bacteria in PJI. In patients with acute PJI (i.e., <1 month following the implantation), DAIR with exchange of removal components followed by a combination of antibiotics including rifampin (RMP) (particularly RMP + fluoroquinolone) are recommended....

Descripción completa

Detalles Bibliográficos
Autores principales:	Becker, Agathe, Triffault-Fillit, Claire, Forestier, Emmanuel, Lesens, Olivier, Boyer, Bertrand, Descamps, Stéphane, Chidiac, Christian, Lustig, Sébastien, Montbarbon, Eric, Batailler, Cécile, Cazorla, Celine, Ferry, Tristan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252675/ http://dx.doi.org/10.1093/ofid/ofy210.1043

Ejemplares similares

Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France
por: Becker, A., et al.
Publicado: (2020)

Microbiological Epidemiology Depending on Time to Occurrence of Prosthetic Joint Infection (PJI): Impact on the Empirical Antimicrobial Strategies
por: Ferry, Tristan, et al.
Publicado: (2017)

Early Staphylococcal Periprosthetic Joint Infection (PJI) Treated with Debridement, Antibiotics, and Implant Retention (DAIR): Inferior Outcomes in Patients with Staphylococci Resistant to Rifampicin
por: Eriksson, Hannah K., et al.
Publicado: (2023)

Salvage Debridement, Antibiotics and Implant Retention (“DAIR”) With Local Injection of a Selected Cocktail of Bacteriophages: Is It an Option for an Elderly Patient With Relapsing Staphylococcus aureus Prosthetic-Joint Infection?
por: Ferry, Tristan, et al.
Publicado: (2018)

Development of an innovative in vivo model of PJI treated with DAIR
por: Poilvache, Hervé, et al.
Publicado: (2022)

1306. Lower Treatment Failure Rates in Patients with Non-Staphylococcal Prosthetic Joint Infections (PJI) Treated with Debridement and Implant Retention (DAIR) Receiving Chronic Antibiotic Suppression (CAS)
por: Sekar, Poorani, et al.
Publicado: (2023)

Correction of Linezolid-Induced Myelotoxicity After Switch to Tedizolid in a Patient Requiring Suppressive Antimicrobial Therapy for Multidrug-Resistant Staphylococcus epidermidis Prosthetic-Joint Infection
por: Ferry, Tristan, et al.
Publicado: (2018)

Pseudomonas aeruginosa Implant-Associated Bone and Joint Infections: Experience in a Regional Reference Center in France
por: Cerioli, Matteo, et al.
Publicado: (2020)

Truth in DAIR: Duration of Therapy and the Use of Quinolone/Rifampin-Based Regimens After Debridement and Implant Retention for Periprosthetic Joint Infections
por: Tai, Don Bambino Geno, et al.
Publicado: (2022)

Does a New Antibiotic Scheme Improve the Outcome of Staphylococcus aureus-Caused Acute Prosthetic Joint Infections (PJI) Treated with Debridement, Antibiotics and Implant Retention (DAIR)?
por: Auñón, Álvaro, et al.
Publicado: (2022)

Reply to Scheper and de Boer's comment on “Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France” by Becker et al. (2020)
por: Becker, Agathe, et al.
Publicado: (2020)

991. Single Center, Exploratory, Open-label Prospective Study Using the Minimally Invasive LysinDAIR Procedure (Lysin Administration During an Arthroscopic DAIR Procedure) in Patients with Suspected Relapsing Chronic Coagulase-Negative Staphylococci (CNS) Prosthetic Hip Infection (PHI)
por: Ferry, Tristan, et al.
Publicado: (2022)

1293. Efficacy of Doxycycline in Staphylococcal Prosthetic Joint Infection Treated with Debridement, Antibiotics and Implant Retention (DAIR) or Revision with Destination Spacer Placement
por: Jang, Timothy, et al.
Publicado: (2023)

Adjunctive Rifampin Following Debridement and Implant Retention for Staphylococcal Prosthetic Joint Infection: Is it Effective if not Combined With a Fluoroquinolone?
por: Cortés-Penfield, Nicolás W, et al.
Publicado: (2022)

Medical innovations to maintain the function in patients with chronic PJI for whom explantation is not desirable: a pathophysiology-, multidisciplinary-, and experience-based approach
por: Ferry, Tristan, et al.
Publicado: (2020)

Pressure ulcer-related pelvic osteomyelitis: evaluation of a two-stage surgical strategy (debridement, negative pressure therapy and flap coverage) with prolonged antimicrobial therapy
por: Andrianasolo, Johan, et al.
Publicado: (2018)

Pressure Ulcer-Related Pelvic Osteomyelitis: Evaluation of a Two-Stage Surgical Strategy (Debridement, Negative Pressure Therapy and Flap Coverage) with Prolonged Antimicrobial Therapy
por: Ferry, Tristan, et al.
Publicado: (2017)

Corynebacterium Bone and Joint Infection (BJI): A Retrospective Cohort Study in a Reference Center for BJI Management
por: Ferry, Tristan, et al.
Publicado: (2017)

Timing of debridement, antibiotics, and implant retention (DAIR) for early post-surgical hip and knee prosthetic joint infection (PJI) does not affect 1-year re-revision rates: data from the Dutch Arthroplasty Register
por: van der Ende, Barry, et al.
Publicado: (2021)

400. Comparison of Tolerance and Microbiological Efficacy of Cefepime and Piperacillin/Tazobactam in Combination with Vancomycin as Empirical Antimicrobial Therapy of Prosthetic Joint Infection: A Propensity-Matched Cohort Study
por: Triffault-Fillit, Claire, et al.
Publicado: (2019)

Subcutaneous Suppressive Antibiotic Therapy for Bone and Joints Infections: Safety and Outcome in a Cohort of 10 Patients
por: Ferry, Tristan, et al.
Publicado: (2017)

Microbiological Epidemiology in Patients Experiencing Microbiological or Clinical Failure Following Reimplantation After a Two-Stage Exchange Strategy for Hip or Knee Prosthetic Joint Infection (PJI)
por: Ferry, Tristan, et al.
Publicado: (2017)

The Potential Innovative Use of Bacteriophages Within the DAC(®) Hydrogel to Treat Patients With Knee Megaprosthesis Infection Requiring “Debridement Antibiotics and Implant Retention” and Soft Tissue Coverage as Salvage Therapy
por: Ferry, Tristan, et al.
Publicado: (2020)

DAIR (Debridement, Antibiotics and Implant Retention) less effective in hematogenous total knee arthroplasty infections
por: Iza, Kattalin, et al.
Publicado: (2019)

691 Rifampin in the Treatment of Staphylococcal Prosthetic Joint Infections
por: Parsaei, Shadi, et al.
Publicado: (2014)

927 Rifampin for Surgically Treated Staphylococcal Infective Endocarditis
por: Shrestha, Nabin, et al.
Publicado: (2014)

395. Safety and Tolerability of Rifampin in Staphylococcal Orthopedic Infections
por: Miller, Andy O, et al.
Publicado: (2019)

The DAIR (debridement, antibiotics and implant retention) procedure for infected total knee replacement – a literature review
por: Qasim, Sultan Naseer, et al.
Publicado: (2017)

381. Clinical Outcome of Polymicrobial Prosthetic Joint Infection Managed with Debridement, Antibiotics, and Implant Retention (DAIR)
por: Hooshmand, Babak, et al.
Publicado: (2019)

Risk factors affect success rate of debridement, antibiotics and implant retention (DAIR) in periprosthetic joint infection
por: Xu, Yihong, et al.
Publicado: (2020)

Use of rifampin in persistent coagulase negative staphylococcal bacteremia in neonates
por: van der Lugt, N Margreth, et al.
Publicado: (2010)

Arthroscopic “Debridement and Implant Retention” With Local Administration of Exebacase (Lysin CF-301) Followed by Suppressive Tedizolid as Salvage Therapy in Elderly Patients for Relapsing Multidrug-Resistant S. epidermidis Prosthetic Knee Infection
por: Ferry, Tristan, et al.
Publicado: (2021)

One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome
por: Byren, I., et al.
Publicado: (2009)

One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome
por: Byren, I., et al.
Publicado: (2011)

One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome
por: Byren, I., et al.
Publicado: (2013)

Trou d'air
por: Simonnet, Cyrille
Publicado: (2005)

Debridement, antibiotics and implant retention (DAIR) is successful in the management of acutely infected unicompartmental knee arthroplasty: a case series
por: Brivio, Angela, et al.
Publicado: (2023)

Accuracy of a Novel Preoperative Failure Risk Model for Debridement Antibiotics and Implant Retention (DAIR) in Acute Prosthetic Joint Infection
por: Sancho, Ignacio, et al.
Publicado: (2022)

One-stage revision versus debridement, antibiotics, and implant retention (DAIR) for acute prosthetic knee infection: an exploratory cohort study
por: Okafor, Charles Ebuka, et al.
Publicado: (2023)

Case Report: Arthroscopic “Debridement Antibiotics and Implant Retention” With Local Injection of Personalized Phage Therapy to Salvage a Relapsing Pseudomonas Aeruginosa Prosthetic Knee Infection
por: Ferry, Tristan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_08u6163rqq00guq5prcqbf5cpd